| __timestamp | Halozyme Therapeutics, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 75334000 | 20272000000 |
| Thursday, January 1, 2015 | 135057000 | 19652000000 |
| Friday, January 1, 2016 | 146691000 | 21903000000 |
| Sunday, January 1, 2017 | 316613000 | 22385000000 |
| Monday, January 1, 2018 | 151862000 | 18854000000 |
| Tuesday, January 1, 2019 | 195992000 | 16887000000 |
| Wednesday, January 1, 2020 | 267594000 | 16658000000 |
| Friday, January 1, 2021 | 443310000 | 15878000000 |
| Saturday, January 1, 2022 | 660116000 | 14925000000 |
| Sunday, January 1, 2023 | 829253000 | 15846000000 |
| Monday, January 1, 2024 | 1015324000 | 16544000000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, Teva Pharmaceutical Industries Limited and Halozyme Therapeutics, Inc. have showcased distinct revenue trajectories over the past decade. From 2014 to 2023, Teva consistently outperformed Halozyme in terms of revenue, with Teva's earnings peaking in 2017 at approximately $22 billion. However, a notable decline followed, with revenues dropping by about 29% by 2022. In contrast, Halozyme's revenue, though significantly lower, demonstrated a remarkable growth trajectory, increasing by over 1,000% from 2014 to 2023. This growth reflects Halozyme's strategic advancements and market adaptability. As of 2023, while Teva's revenue stabilized around $15.8 billion, Halozyme reached a new high of $829 million. This data underscores the dynamic shifts within the pharmaceutical industry, highlighting the importance of innovation and strategic positioning.
AbbVie Inc. and Halozyme Therapeutics, Inc.: A Comprehensive Revenue Analysis
AstraZeneca PLC or Halozyme Therapeutics, Inc.: Who Leads in Yearly Revenue?
Comparing Revenue Performance: Zoetis Inc. or Teva Pharmaceutical Industries Limited?
Who Generates More Revenue? GSK plc or Teva Pharmaceutical Industries Limited
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited or Jazz Pharmaceuticals plc: Who Leads in Yearly Revenue?
Teva Pharmaceutical Industries Limited vs MiMedx Group, Inc.: Examining Key Revenue Metrics
Revenue Showdown: Viatris Inc. vs Halozyme Therapeutics, Inc.
Revenue Insights: Ascendis Pharma A/S and Halozyme Therapeutics, Inc. Performance Compared
Halozyme Therapeutics, Inc. or Lantheus Holdings, Inc.: Who Leads in Yearly Revenue?
Comparing Revenue Performance: Halozyme Therapeutics, Inc. or Corcept Therapeutics Incorporated?
Halozyme Therapeutics, Inc. vs Veracyte, Inc.: Annual Revenue Growth Compared